Kim Robert Y, Shen Sui, Duan Jun
Department of Radiation Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, 1824 6th Avenue South, Birmingham, AL 35249, USA.
Brachytherapy. 2007 Jul-Sep;6(3):187-94. doi: 10.1016/j.brachy.2006.11.005. Epub 2007 Jul 2.
The purpose of this study was to evaluate dose-volume histograms (DVHs) of bladder, rectum, sigmoid colon, and small bowel using image-based three-dimensional treatment planning for intracavitary brachytherapy.
Between 2001 and 2003, 22 patients with cancer of the cervix (1 IB1, 5 IB2, 11 IIB, 5 IIIB) were treated with computerized tomography (CT)-compatible high-dose-rate intracavitary applicators and underwent postimplant pelvic CT scans with the applicator in place. The volumes of organs at risk were digitized. For radiography-based planning, International Commission on Radiation Units and Measurements (ICRU) bladder and rectum point doses were calculated. For the CT-based planning, the DVHs were computed for the bladder, rectum, sigmoid colon, and small bowel. To compare doses to organs at risk, the minimum dose in 2.0cm(3) volume receiving the highest dose (D(2)) was determined from DVHs. These D(2) doses were compared with radiography-based ICRU point doses.
The mean ICRU bladder point dose (401cGy) was markedly underestimated compared to the mean bladder D(2) dose (484cGy). However, the mean ICRU rectal point dose (412cGy) did not differ significantly from the mean rectal D(2) dose (373cGy). The most frequent organ receiving the highest D(2) dose was the sigmoid colon in 9 of 22 patients (41%) followed by the rectum in 7 of 22 patients (32%) and small bowel in 6 of 22 patients (27%).
From CT-based three-dimensional (3-D) evaluation, the ICRU bladder point dose was substantially lower than bladder D(2) dose. Special attention should also be given to the areas of proximal rectum and sigmoid colon due to more frequent high D(2) dose in these areas.
本研究的目的是使用基于图像的三维腔内近距离放射治疗计划来评估膀胱、直肠、乙状结肠和小肠的剂量体积直方图(DVH)。
在2001年至2003年期间,22例宫颈癌患者(1例IB1期、5例IB2期、11例IIB期、5例IIIB期)接受了与计算机断层扫描(CT)兼容的高剂量率腔内施源器治疗,并在施源器就位的情况下进行了植入后盆腔CT扫描。对危及器官的体积进行数字化处理。对于基于放射照相的计划,计算国际辐射单位与测量委员会(ICRU)膀胱和直肠点剂量。对于基于CT的计划,计算膀胱、直肠、乙状结肠和小肠的DVH。为了比较危及器官的剂量,从DVH中确定接受最高剂量(D(2))的2.0cm(3)体积中的最小剂量。将这些D(2)剂量与基于放射照相的ICRU点剂量进行比较。
与平均膀胱D(2)剂量(484cGy)相比,平均ICRU膀胱点剂量(401cGy)被明显低估。然而,平均ICRU直肠点剂量(412cGy)与平均直肠D(2)剂量(373cGy)没有显著差异。接受最高D(2)剂量最常见的器官是22例患者中的9例(41%)乙状结肠,其次是22例患者中的7例(32%)直肠和22例患者中的6例(27%)小肠。
基于CT的三维(3-D)评估显示,ICRU膀胱点剂量明显低于膀胱D(2)剂量。由于直肠近端和乙状结肠区域更频繁地出现高D(2)剂量,因此也应特别关注这些区域。